retatrutide dosing in clinical trials Reta trial data & — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied Phase 3 for metabolic health — targeting GLP-1, GIP ESC 2024: Retatrutide improves lipid

Postoperative changes Following bariatric surgery, there is a significant increase in total bile acids, which exert metabolic effects through receptors such as TGR5, impacting both the gut-brain axis and the peripherally system [70]

Its rooted in what actually works

Accumulation of polyphenolic compounds and osmolytes under dehydration stress and their implication in redox regulation in four Indigenous aromatic rice cultivars

In patients with Crohns disease (CD) and ulcerative colitis (UC), higher amounts of Escherichia coli have been observed pointing to the possibility that administration of PPIs would further induce these infections (Bruno et al

Qs next: The diverse functions of glutamine in metabolism, cell biology and cancer

While these routines definitely matter, they don't directly replenish glutathione